Spine Pain Market

Spine Pain Market Size by Disease Type (Sub-Acute, Acute, and Chronic), End-Use (Orthopedic Clinics, Hospitals, Ambulatory Surgery Centres, and Others), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2031

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13264
  • Published Date: Jan, 2023
  • Pages: 110
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global spine pain market was valued at USD 9.7 billion in 2023 and growing at a CAGR of 4.80% from 2023 to 2031. The market is expected to reach USD 14.11 billion by 2031. A growth in nerve cases and the geriatric population is the primary reason for the expansion of the spine pain market. Also, sedentary lifestyles, increasing healthcare awareness among developed & underdeveloped countries and rising disposable income of customers are the elements that are anticipated to push the market growth.

Market Introduction:

Spinal pain in the lumbar (lower back) and cervical area (neck) is dominant and often causes many chronic to severe pain. Lumbar muscle strains and sprains are the most common reasons for low back pain. The thoracic spine can also be a site of spinal pain, but it is much more rigid; the thoracic spinal area is much less often injured than the lumbar and cervical spine. The cervical and lumbar spine are prone to stress due to their weight-bearing function and involvement in twisting, moving, and bending. Lumbar muscle strain is caused when muscle fibers are abnormally stretched or torn. A lumbar sprain is caused when ligaments, the rugged bands of tissue that hold bones together, are unusually stretched. Both can result from a sudden injury or gradual overuse. Spine pain is one of the most common reasons people self-treats and seeks medical care. It will impact around three in four adults during their lifetime. It’s caused, directly or incidentally, by many health conditions, which may make teasing out the root cause of lower back pain especially tricky. Sometimes the reason is apparent, and sometimes not even a team of doctors can figure out the reason for back pain. Many cases go away independently, but some stick around for months or even years. Muscles that support the spine are structured in layers. Some muscles extend from the base of a person’s skull to the pelvis. Other muscle groups cover shorter distances depending on the segment of the spine, which is thoracic, lumbar, or cervical. Spine pain is the fifth most common reason for physician visits and affects nearly 60-80% of people throughout their lifetime. Some studies have shown that up to 23% of adults globally suffer from chronic spine pain. The population also shows a one-year recurrence rate of 24% to 80%. Some estimates of lifetime majority are as high as 84% in the adult population. A systematic review demonstrated an annual rate of adolescents suffering from back pain of 11.8% to 33%. 11-12% of the population is disabled by low back pain.

Spine Pain Market

Get an overview of this study by requesting a free sample

Recent Development

In May 2019: the company of Kaia Health, pain management specialists, and physicians designed and founded an artificial intelligence-based low back pain management app, Kaia app, to educate and spread awareness about the prevention of spine pain amongst the population.

In November 2022: Cigna's health services arm Evernorth will be a minority owner in VillageMD after it invested in the primary care disruptor's acquisition of Summit Health. Evernorth's collaboration with VillageMD is part of its effort to accelerate value-based services, the company said. The deal is expected to close in the first quarter of 2023.

Market Dynamics:

Drivers

The Rise in Nerve Problem- The spine market is expected to be driven by a sedentary lifestyle and a rise in nerve cases. The advanced use of novel antidepressants and the rising geriatric population are other essential elements pushing the market's growth. The market is predicted to experience additional growth prospects within the forecast years due to increasing research and development, particularly in spine back pain.

More effective physical therapy- Getting a reprieve from back pain can allow the person to take more of an active role in the physical therapy routines, which tends to produce better long-term results. 

Restraints:

It's A Passive Treatment- When the patient takes pain medicines, it's not actively treating or addressing the source of the back pain, which implies the person is not doing anything to target spine-supporting muscles or promote healing.

Opportunities:

An Increasing Number of Individuals- The market expansion is helped by the increasing number of individuals in the area who suffer from constant lower back pain. The market growth for spine pain in North America is hustling due to increasing healthcare spending by the people and the existence of advanced healthcare infrastructure. In the forthcoming years, it is expected that growing research measures to determine the root causes of spine pain and create better treatment alternatives will stimulate market growth.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest market for the global spine pain market, with a 37.6% share of the market revenue in 2023.

North America dominates the spine pain market due to increased understanding of the availability of treatment processes for different chronic diseases is pushing up the market's need in the region. The Asia Pacific spine pain market is expected to rise at the fastest pace during the projection years due to the rising geriatric population and number of surgeries in the region. India, China, & Japan can contribute significantly to the region's market growth. As per the World population, the United States has the highest ageing population, with an estimated population of 143 million in 2019 to 426 million in 2050, followed by the APAC region.

North America Region Spine Pain Market Share in 2023 - 37.6%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Disease Type Segment Analysis

The disease type segment is divided into sub-acute, acute, and chronic. The chronic segment dominated the market, with a market share of around 34% in 2023. An expansion in nerve cases and an upsurge in the geriatric population is the primary growth driver for the chronic spine pain market. For example, as per the National Institute of Neurological Disorders and Stroke, about 80% of adults experience lower back pain at some stage due to an inactive lifestyle.

End-Use Segment Analysis

The end-use segment is divided into orthopedic clinics, hospitals, ambulatory surgery centres, and others. The orthopedic clinics segment dominated the market, with a market share of around 27% in 2023. Orthopedic physicians can deliver long-term comfort from back pain by using various methods for pain reduction, including injections, medication, and physical therapy. Many orthopedic physicians are also orthopedic surgeons.

Some of the Key Market Players:
  • Astellas Pharma Inc.
  • BioWave Corporation
  • Boston Scientific Corporation
  • CELGENE CORPORATION
  • Dr. Reddy's Laboratories Ltd.
  • Endo Pharmaceuticals Inc.
  • Johnson & Johnson Private Limited
  • Koninklijke Philips N.V.
  • Medtronic
  • Merck & Co Inc.
  • Pfizer Inc
  • Sanofi
  • SpineThera Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Vertebral Technologies, Inc.

Report Description:

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2023 USD 9.7 Billion
Market size value in 2031 USD 14.11 Billion
CAGR (2023 to 2031) 4.80%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2031
Regional Segments The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
Segments Disease Type, End-Use

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Disease Type
          4.3.2. Market Attractiveness Analysis by End-Use
          4.3.3. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. The rise in nerve problem
    5.3. Restraints
          5.3.1. It's a passive treatment
    5.4. Opportunities
          5.4.1. An increasing number of individuals

6. Global Spine Pain Market Analysis and Forecast, By Disease Type:
    6.1. Segment Overview
    6.2. Sub-Acute
    6.3. Acute
    6.4. Chronic

7. Global Spine Pain Market Analysis and Forecast, By End-Use
    7.1. Segment Overview
    7.2. Orthopaedic Clinics
    7.3. Hospitals
    7.4. Ambulatory Surgery Centres
    7.5. Others

8. Global Spine Pain Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
    8.5. South America
          8.5.1. Brazil
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa

9. Global Spine Pain Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in the Spine Pain Market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Product Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions

10. Company Profiles
    10.1. Astellas Pharma Inc
          10.1.1. Business Overview
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Product Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. BioWave Corporation
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Product Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. CELGENE CORPORATION
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Product Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. Dr. Reddy's Laboratories Ltd.
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Product Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. Endo Pharmaceuticals Inc.
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Product Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. Johnson & Johnson Private Limited
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Product Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. Koninklijke Philips N.V.
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Product Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. Medtronic.
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Product Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
    10.9. Merck & Co Inc.
          10.9.1. Business Overview
          10.9.2. Company Snapshot
          10.9.3. Company Market Share Analysis
          10.9.4. Company Product Portfolio
          10.9.5. Recent Developments
          10.9.6. SWOT Analysis
    10.10. Pfizer Inc.
          10.10.1. Business Overview
          10.10.2. Company Snapshot
          10.10.3. Company Market Share Analysis
          10.10.4. Company Product Portfolio
          10.10.5. Recent Developments
          10.10.6. SWOT Analysis
    10.11. Sanofi.
          10.11.1. Business Overview
          10.11.2. Company Snapshot
          10.11.3. Company Market Share Analysis
          10.11.4. Company Product Portfolio
          10.11.5. Recent Developments
          10.11.6. SWOT Analysis
    10.12. SpineThera Inc.
          10.12.1. Business Overview
          10.12.2. Company Snapshot
          10.12.3. Company Market Share Analysis
          10.12.4. Company Product Portfolio
          10.12.5. Recent Developments
          10.12.6. SWOT Analysis
    10.13. Teva Pharmaceutical Industries Ltd.
          10.13.1. Business Overview
          10.13.2. Company Snapshot
          10.13.3. Company Market Share Analysis
          10.13.4. Company Product Portfolio
          10.13.5. Recent Developments
          10.13.6. SWOT Analysis
    10.14. Vertebral Technologies, Inc.
          10.14.1. Business Overview
          10.14.2. Company Snapshot
          10.14.3. Company Market Share Analysis
          10.14.4. Company Product Portfolio
          10.14.5. Recent Developments
          10.14.6. SWOT Analysis
 

List of Table

1. Global Spine Pain Market, By Disease Type, 2019-2031 (USD Billion) 

2. Global Sub-Acute Spine Pain Market, By Region, 2019-2031 (USD Billion) 

3. Global Acute Spine Pain Market, By Region, 2019-2031 (USD Billion) 

4. Global Chronic Spine Pain Market, By Region, 2019-2031 (USD Billion) 

5. Global Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

6. Global Orthopedic Clinics Spine Pain Market, By Region, 2019-2031 (USD Billion) 

7. Global Hospital Spine Pain Market, By Region, 2019-2031 (USD Billion)

8. Global Ambulatory Surgery Centres Spine Pain Market, By Region, 2019-2031 (USD Billion)

9. Global Others Spine Pain Market, By Region, 2019-2031 (USD Billion)

10. North America Spine Pain Market, By Disease Type, 2019-2031 (USD Billion) 

11. North America Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

12. U.S. Spine Pain Market, By Disease Type, 2019-2031 (USD Billion) 

13. U.S. Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

14. Canada Spine Pain Market, By Disease Type, 2019-2031 (USD Billion) 

15. Canada Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

16. Mexico Spine Pain Market, By Disease Type, 2019-2031 (USD Billion) 

17. Mexico Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

18. Europe Spine Pain Market, By Disease Type, 2019-2031 (USD Billion) 

19. Europe Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

20. Germany Spine Pain Market, By Disease Type, 2019-2031 (USD Billion) 

21. Germany Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

22. France Spine Pain Market, By Disease Type 2019-2031 (USD Billion) 

23. France Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

24. U.K. Spine Pain Market, By Disease Type, 2019-2031 (USD Billion) 

25. U.K. Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

26. Italy Spine Pain Market, By Disease Type, 2019-2031 (USD Billion) 

27. Italy Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

28. Spain Spine Pain Market, By Disease Type, 2019-2031 (USD Billion) 

29. Spain Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

30. Asia Pacific Spine Pain Market, By Disease Type, 2019-2031 (USD Billion) 

31. Asia Pacific Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

32. Japan Spine Pain Market, By Disease Type, 2019-2031 (USD Billion) 

33. Japan Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

34. China Spine Pain Market, By Disease Type 2019-2031 (USD Billion) 

35. China Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

36. India Spine Pain Market, By Disease Type 2019-2031 (USD Billion) 

37. India Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

38. South America Spine Pain Market, By Disease Type, 2019-2031 (USD Billion) 

39. South America Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

40. Brazil Spine Pain Market, By Disease Type 2019-2031 (USD Billion) 

41. Brazil Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

42. Middle East and Africa Spine Pain Market, By Disease Type, 2019-2031 (USD Billion) 

43. Middle East and Africa Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

44. UAE Spine Pain Market, By Disease Type, 2019-2031 (USD Billion) 

45. UAE Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

46. South Africa Spine Pain Market, By Disease Type 2019-2031 (USD Billion) 

47. South Africa Spine Pain Market, By End-Use, 2019-2031 (USD Billion) 

List of Figures 

1. Global Spine Pain Market Segmentation

2. Spine Pain Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Spine Pain Market Attractiveness Analysis by Disease Type

9. Global Spine Pain Market Attractiveness Analysis by End-Use

10. Global Spine Pain Market Attractiveness Analysis by Region

11. Global Spine Pain Market: Dynamics

12. Global Spine Pain Market Share by Disease Type (2023 & 2031)

13. Global Spine Pain Market Share by End-Use (2023 & 2031)

14. Global Spine Pain Market Share by Regions (2023 & 2031)

15. Global Spine Pain Market Share by Company (2022)

This study forecasts revenue at global, regional, and country levels from 2019 to 2031. The Brainy Insights has segmented the global spine pain market based on below mentioned segments:

Global Spine Pain Market Type:

  • Sub-Acute
  • Acute
  • Chronic

Global Spine Pain Market End-Use

  • Orthopedic Clinics
  •  Hospitals
  • Ambulatory Surgery Centres
  • Others

Global Spine Pain Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date